Pre-commercial public procurement of R+D services in the field of single-use bioreactor platforms for the production of biopharmaceuticals based on autologous cells, financed by the Recovery and Resilience Facility (RRF), within the framework of the Recovery, Transformation and Resilience Plan (PRTR)
Pre-commercial public procurement of R+D services in the field of single-use bioreactor platforms for the production of biopharmaceuticals based on autologous cells, financed by the Recovery and Resilience Facility (RRF), within the framework of the Recovery, Transformation and Resilience Plan (PRTR)